Novel cyclic biphalin analogue with improved antinociceptive properties.

Two novel opioid analogues have been designed by substituting the native d-Ala residues in position 2,2' of biphalin with two residues of d-penicillamine or l-penicillamine and by forming a disulfide bond between the thiol groups. The so-obtained compound 9 containing d-penicillamines showed excellent μ/δ mixed receptor affinities (K i (δ) = 5.2 nM; K i (μ) = 1.9 nM), together with an efficacious capacity to trigger the second messenger and a very good in vivo antinociceptive activity, whereas product 10 was scarcely active. An explanation of the two different pharmacological behaviors of products 9 and 10 was found by studying their conformational properties.

[1]  V. Hruby,et al.  Biological active analogues of the opioid peptide biphalin: mixed α/β(3)-peptides. , 2013, Journal of medicinal chemistry.

[2]  A. Mollica,et al.  Antinociceptive profile of potent opioid peptide AM94, a fluorinated analogue of biphalin with non‐hydrazine linker , 2013, Journal of peptide science : an official publication of the European Peptide Society.

[3]  A. Mollica,et al.  Structure-activity relationships of biphalin analogs and their biological evaluation on opioid receptors. , 2012, Mini reviews in medicinal chemistry.

[4]  M. Vacca,et al.  The analgesic activity of biphalin and its analog AM 94 in rats. , 2012, European journal of pharmacology.

[5]  V. Hruby,et al.  The cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues. , 2012, Journal of medicinal chemistry.

[6]  V. Hruby,et al.  cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues: part 2. , 2012, Journal of medicinal chemistry.

[7]  M. Palmery,et al.  Guinea pig ileum motility stimulation elicited by N-formyl-Met-Leu-Phe (fMLF) involves neurotransmitters and prostanoids , 2011, Peptides.

[8]  R. Egleton,et al.  Development of neuropeptide drugs that cross the blood-brain barrier , 2011, NeuroRX.

[9]  E. Novellino,et al.  Novel octreotide dicarba-analogues with high affinity and different selectivity for somatostatin receptors. , 2010, Journal of medicinal chemistry.

[10]  P. Schiller,et al.  N‐Methylated Cyclic Enkephalin Analogues Retain High Opioid Receptor Binding Affinity , 2010, Chemical biology & drug design.

[11]  A. Magyar,et al.  Selective and high affinity labeling of neuronal and recombinant nociceptin receptors with the hexapeptide radioprobe [3H]Ac-RYYRIK-ol , 2009, Neurochemistry International.

[12]  V. Hruby,et al.  The importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists. , 2008, Journal of medicinal chemistry.

[13]  C. Czaplewski,et al.  Deltorphin analogs restricted via a urea bridge: structure and opioid activity , 2008, Journal of peptide science : an official publication of the European Peptide Society.

[14]  C. Hwang,et al.  Structure−Activity Relationships of αS1-Casomorphin Using AM1 Calculations and Molecular Dynamics Simulations , 2007 .

[15]  V. Hruby,et al.  Synthesis of Stable and Potent δ/μ Opioid Peptides: Analogues of H-Tyr-c[d-Cys-Gly-Phe-d-Cys]-OH by Ring-Closing Metathesis , 2007 .

[16]  P. Schiller,et al.  Dicarba analogues of the cyclic enkephalin peptides H-Tyr-c[D-Cys-Gly-Phe-D(or L)-Cys]NH(2) retain high opioid activity. , 2007, Journal of medicinal chemistry.

[17]  V. Hruby,et al.  Synthesis and biological activity of the first cyclic biphalin analogues. , 2006, Bioorganic & medicinal chemistry letters.

[18]  M. S. Cepeda,et al.  Analgesic activity of a novel bivalent opioid peptide compared to morphine via different routes of administration , 1991, Agents and Actions.

[19]  M. Rocha e Silva,et al.  Release of kinin-like material in rats submitted to hyperthermia (40–43°C) , 1973, Agents and Actions.

[20]  M. Perretti,et al.  Stimulus-dependent specificity for annexin 1 inhibition of the inflammatory nociceptive response: the involvement of the receptor for formylated peptides , 2004, Pain.

[21]  L. Gentilucci.  New trends in the development of opioid peptide analogues as advanced remedies for pain relief. , 2004, Current topics in medicinal chemistry.

[22]  M. Spetea,et al.  Synthesis and Biological Evaluation of 14‐Alkoxymorphinans. Part 19 , 2003 .

[23]  V. Hruby.  Designing peptide receptor agonists and antagonists , 2002, Nature Reviews Drug Discovery.

[24]  A. Péter,et al.  In vitro quantitative study of the degradation of endomorphins , 2002, Peptides.

[25]  A. Lipkowski,et al.  The opioid peptide analogue biphalin induces less physical dependence than morphine. , 2001, Life sciences.

[26]  P. Portoghese,et al.  From models to molecules: opioid receptor dimers, bivalent ligands, and selective opioid receptor probes. , 2001, Journal of medicinal chemistry.

[27]  V. Hruby,et al.  A three-dimensional model of the delta-opioid pharmacophore: comparative molecular modeling of peptide and nonpeptide ligands. , 2000, Biopolymers.

[28]  V. Hruby,et al.  Biological activity of fragments and analogues of the potent dimeric opioid peptide, biphalin. , 1999, Bioorganic & medicinal chemistry letters.

[29]  P. Szekeres,et al.  Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects. , 1997, The Journal of pharmacology and experimental therapeutics.

[30]  V. Hruby,et al.  Brain and Spinal Cord Distribution of Biphalin: Correlation with Opioid Receptor Density and Mechanism of CNS Entry , 1997, Journal of neurochemistry.

[31]  D. Selley,et al.  In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Traynor,et al.  Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. , 1995, Molecular pharmacology.

[33]  V. Hruby,et al.  Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  L. Kabasakal,et al.  Binding characteristics of the novel highly selective delta agonist, [3H]Ile5,6deltorphin II , 1994, Neuropeptides.

[35]  V. Hruby,et al.  In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands. , 1993, The Journal of pharmacology and experimental therapeutics.

[36]  S. Appleyard,et al.  Antinociceptive profile of biphalin, a dimeric enkephalin analog. , 1993, The Journal of pharmacology and experimental therapeutics.

[37]  T. Yamazaki,et al.  A topochemical approach to explain morphiceptin bioactivity. , 1993, Journal of medicinal chemistry.

[38]  V. Hruby,et al.  Conformational analysis of enkephalin analogs containing a disulfide bond. Models for delta- and mu-receptor opioid agonists. , 2009, International journal of peptide and protein research.

[39]  V. Hruby,et al.  Recent developments in the design of receptor specific opioid peptides , 1989, Medicinal research reviews.

[40]  W. Burkard,et al.  Synthesis and biological evaluation of 14-alkoxymorphinans. 2. (-)-N-(cyclopropylmethyl)-4,14-dimethoxymorphinan-6-one, a selective mu opioid receptor antagonist. , 1989, Journal of medicinal chemistry.

[41]  R. Sebaldt.  Manual of Pharmacologic Calculations with Computer Programs. Second Edition , 1988 .

[42]  T F Burks,et al.  Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Konecka,et al.  Double-enkephalins—Synthesis, activity on guinea-pig ileum, and analgesic effect , 1982, Peptides.

[44]  V. Hruby,et al.  [D-Pen2, L-Cys5]enkephalinamide and[D-Pen2, D-Cys5] enkephalinamide, conformationally constrained cyclic enkephalinamide analogs with delta receptor specificity. , 1982, Biochemical and biophysical research communications.

[45]  R. H. Walmsley,et al.  Manual of pharmacologic calculations with computer programs , 1982 .